Quantcast

Latest tumor Stories

2014-10-22 23:06:03

Six new members elected at ABTA annual meeting Chicago, IL (PRWEB) October 22, 2014 The American Brain Tumor Association (ABTA) – the first and now only organization to fund brain tumor research and provide education and information on all tumor types for all ages – has elected six new members to its Board of Directors as well as the full slate of officers at its recent annual meeting in Chicago. “It is a privilege to welcome new members to the ABTA’s Board of Directors who...

2014-10-17 08:25:10

Trial Has Not Yet Reached Necessary Number of Survival Events to Report on Overall Survival Due to Longer than Expected Survival of Study Patients LOS ANGELES, Oct. 17, 2014 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, announced that data regarding the Company's Phase 2b global clinical trial of aldoxorubicin for the treatment of first-line soft tissue sarcoma (STS) will be presented in a moderated...

2014-10-16 08:30:40

Combines NGS and FISH Testing for Comprehensive Cancer Profiling FT. MYERS, Fla., Oct. 16, 2014 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today the addition of a new comprehensive solid tumor profiling test designed for clinical discovery and to support clinical trials. The test utilizes next generation sequencing ("NGS") to analyze variants in the coding sequence of 315 genes and uses conventional...

2014-10-14 23:09:45

Market Size - $174.14 billion in 2013, Market Growth - CAGR of 6.0%, Market Trends - Growing demand for early disease diagnosis - Latest report by Grand View Research. View full report with TOC - http://www.grandviewresearch.com/industry-analysis/clinical-laboratory-services-market. San Francisco, California (PRWEB) October 14, 2014 Global clinical laboratory services market is expected to reach USD 261.42 billion by 2020, according to a new study by Grand View Research, Inc. The demand...

2014-10-14 04:22:05

TUBINGEN, Germany, October 14, 2014 /PRNewswire/ -- Regulatory authority approves clinical trial for Glioma Actively Personalized Vaccine Consortium (GAPVAC) First centers to enroll glioblastoma patients opened in Heidelberg and Tuebingen European Union supports the initiative with a EUR6 million grant immatics biotechnologies GmbH and BioNTech AG announce...

2014-10-09 08:28:21

Preclinical Data Indicates Targeting Hyaluronan in the Tumor Stroma May Offer A New Approach to Pancreatic Cancer Treatment SAN DIEGO, Oct. 9, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced an oral presentation on the pharmacology of PEGPH20 at the New York Academy of Sciences symposium "Targeting Key Vulnerabilities in Pancreatic Cancer," being held on October 9, 2014 in New York City. The presentation includes preclinical data showing that...

2014-10-09 08:27:59

DelMar Pharmaceuticals Presents Data at AACR's New Horizons in Cancer Research Conference in Shanghai, China VANCOUVER, British Columbia, MENLO PARK, Calif. and SHANGHAI, Oct. 9, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), a clinical-stage oncology company, today announced the presentation of promising new data supporting the activity of its lead drug compound, VAL-083, in the treatment of non-small cell lung cancer (NSCLC) at the AACR's New Horizons in Cancer Research:...

2014-10-09 08:27:10

Program Funded by the National Cancer Institute (NCI) CHARLOTTESVILLE, Va., Oct. 9, 2014 /PRNewswire/ -- HemoShear today announced that it has completed the first phase of development of a novel cancer drug discovery platform that replicates human tumor biology and responds to clinically-relevant drug concentrations. Funded by a contract with the NCI, HemoShear is developing a series of tumor models that recreate a wide variety of cancers for discovery of new drugs. Using their new...

2014-10-08 08:25:53

LEWISVILLE, Texas and CLEVELAND, Oct. 8, 2014 /PRNewswire/ -- med fusion, an integrated molecular center of excellence and clinical trials service organization and GenomOncology, an Ohio based genomics technology and services provider, today announced a partnership to optimize treatment strategies based on the patient's disease state and tumor profile. The companies believe that GenomOncology's proprietary technology platform, the GO Clinical Workbench(TM), and support services will...

2014-10-02 08:28:50

Results, Published in Clinical Genitourinary Cancer, Offer Key Insights and Potential New Treatment Strategies for Patient Population with Limited Drug Options IRVING, Texas, Oct. 2, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced the publication of a study in which Caris Molecular Intelligence(TM), the company's comprehensive tumor profiling service, was used to identify actionable biomarkers in...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin